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Abstract
(S)-2,4-Diaminobutanoic acid (DABA) is a noncanonical amino acid often co-produced by
cyanobacteria along with β-N-methylamino-L-alanine (BMAA) in algal blooms. Although BMAA
is a well-established neurotoxin, the toxicity of DABA remains unclear. As part of our
development of biocompatible materials, we wish to make use of DABA as both a building block
and as the end-product of enzymatically-induced depolymerization; however, if it is toxic at very
low concentrations, this would not be possible. We examined the toxicity of DABA using both in
vivo embryonic and adult zebrafish models. At higher sub-lethal concentrations (700 µM), the fish
demonstrated early signs of cardiotoxicity. Adolescent zebrafish were able to tolerate a higher
concentration. Post-mortem histological analysis of juvenile zebrafish showed no liver or brain
abnormalities associated with hepato- or neurotoxicity. Combined, these results show that DABA
exhibits no overt toxicity at concentrations (100-300 µM) within an order of magnitude of those
envisioned for its application. This study further highlights the low-cost and ease of using zebrafish
as an early-stage toxicological screening tool.
Short Abstract
Zebrafish are used to evaluate the toxicity of (S)-2,4-Diaminobutanoic acid (DABA), a material
useful for next-generation drug delivery nanoparticles. DABA is produced by cyanobacteria and
is toxic at high doses, but no studies have looked at sub-mM concentrations. Below 300 μM we
observe no adverse effects in embryonic, adolescent or adult zebrafish. This is more than an order
of magnitude above the envisioned operation concentration (20 μM). Zebrafish are a useful tool
for early toxicity screening.
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Introduction
DABA is a noncanonical amino acid structurally related to ornithine and lysine in having a sidechain nitrogen (Figure 1). It is produced by cyanobacteria alongside β-N-methylamino-L-alanine
(BMAA) (Al-Sammak, Hoagland, Cassada, & Snow, 2014; Fan, Qiu, Fan, & Li, 2015), a wellknown neurotoxin (Al-Sammak, Rogers, & Hoagland, 2015; Cox et al., 2005; Cox, Davis, Mash,
Metcalf, & Banack, 2016). As this is the major biological source of DABA and as DABA is always
co-expressed with the highly toxic BMAA, determining the toxicity of DABA has not been a high
priority. Nevertheless, the toxicity of DABA has remained a subject of interest and debate as
different studies report substantial variability in their toxicity data (Arscott & Harper, 1963; Beart
& Bilal, 1977; Bergenheim et al., 2006; Chen, Flory, & Koeppe, 1972; Johnston & Twitchin, 1977;
Main & Rodgers, 2018; O'Neal, Chen, Reynolds, Meghal, & Koeppe, 1968). High, but localized
concentrations of DABA selectively kill tumour cells but not healthy glial cells, and have been
investigated as a potential co-therapy for glioblastoma (Bergenheim et al., 2006). Similar elevated
concentrations of DABA have also been associated with liver toxicity and the development of
brain abnormalities in rats (Chen et al., 1972; Johnston & Twitchin, 1977; Mushahwar & Koeppe,
1963; O'Neal et al., 1968), and chicks (Arscott & Harper, 1963), possibly through inhibiting
reuptake of GABA (Beart & Bilal, 1977; Main & Rodgers, 2018). High concentrations of BMAA
reduced the life span in Drosophila models, decreased locomotor function, decreased learning and
memory, reduced fertility in females, and delayed neurological impairment in aged adults (Zhou,
Escala, Papapetropoulos, & Zhai, 2010). All of these studies were done using relatively high
concentrations (generally with 1 mM as the lowest investigated concentration) of BMAA or
DABA. The toxicity of a low dose exposure to DABA has not been systematically evaluated in
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vitro or in vivo. The toxicity of low concentrations of DABA are of interest to our groups as we
propose using it as a component of a targeted, traceless, drug delivery capsule.
Targeted drug-delivery is an ever-expanding field in the biomedical sciences (Arpicco et
al., 2016; Bertrand et al., 2014; Noble et al., 2014; Ulbrich et al., 2016). Current methods suffer
from several drawbacks and self-immolative materials may provide a solution to this problem by
allowing for complete degradation to small molecules; however, current systems are not
sufficiently biocompatible (Fan and Gillies, 2015; Fan et al., 2016b; Fan et al., 2018). Selfimmolative materials are compounds that depolymerize, unit-by-unit, when exposed to a particular
stimulus. The polymer we are seeking to create generates DABA as a product and we seek to
evaluate its toxicity and compatibility for this application in an animal model.
Zebrafish have emerged as a highly promising screening system for environmental toxicity
(A. Hill, Howard, Strahle, & Cossins, 2003; A. J. Hill, Teraoka, Heideman, & Peterson, 2005;
Ton, Lin, & Willett, 2006; Van den Bulck et al., 2011). For example, the related BMAA was
recently tested on zebrafish to determine the impact of the compound on development and
progression of amyotrophic lateral sclerosis (ALS). At low BMAA levels, only zebrafish with a
familial ALS-sensitizing mutation were affected by BMAA, wildtype zebrafish remained
unaffected (Powers, Kwok, Lovejoy, Lavin, & Sher, 2017). DABA toxicity has yet to be evaluated
using zebrafish. Consequently, we report the effect of exposure to varying doses of DABA on
zebrafish at different stages of maturation. In this paper, we describe our investigation into the
toxicity of this material and address the suitability for its use in our biomedical self-immolative
polymer technology.
Methods
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Synthesis of DABA. Full synthetic details on the synthesis of DABA can be found in the
accompanying supporting information. Samples of synthetic DABA are available for donation
upon request for collaborative purposes, although the commercial cost has dropped more than 10fold since we initiated this study.
General Experimental Protocols. Solvents were purchased from Caledon Labs (Caledon,
Ontario), Sigma-Aldrich (Oakville, Ontario) or VWR Canada (Mississauga, Ontario). Other
chemicals were purchased from Sigma-Aldrich, AK Scientific, Oakwood Chemicals, Alfa Aesar
or Acros Organics and were used without further purification unless otherwise noted. All heated
reactions were conducted using oil baths on IKA RET Basic stir plates equipped with a P1000
temperature probes. Thin layer chromatography was performed using EMD aluminum-backed
silica 60 F254-coated plates and were visualized using either UV-light (254 nm), KMnO4, vanillin,
Hanessian’s stain, or Dragendorff’s stain. Column chromatography was carried out using standard
flash technique with silica (Siliaflash-P60, 230-400 mesh, Silicycle) using compressed air
pressure. Standard work-up procedure for all reactions undergoing an aqueous wash involved back
extraction of every aqueous phase, a drying of the combined organic phases with anhydrous
magnesium sulphate, filtration either using vacuum and a sintered-glass frit or gravity through
glass wool, and concentration under reduced pressure on a rotary evaporator (Buchi or Synthware)
at 40 °C. 1H NMR spectra were obtained at 300 MHz or 500 MHz, and 13C NMR spectra were
obtained at 75 or 125 MHz on Bruker instruments. NMR chemical shifts (δ) are reported in ppm
and are calibrated against solvent residual signals of CHCl3 (δ 7.26), DMSO-d5 (δ 2.50), HDO (δ
4.79) or methanol-d3 (δ 3.31).
Cell culture. HepG2 liver cancer cells were purchased from ATCC (American Type Culture
Collection): The Global Bioresource Center. The U251 glioma cell line was a kind gift from Dr.
6

Rutka (The Hospital for Sick Children Research Institute, University of Toronto). HepG2 cells
were cultured in EMEM media supplemented with 10% FBS and 30,000 units penicillin/30,000
µg streptomycin solution. U251 cells were cultured in DMEM media supplemented with 10% FBS
and 30,000 units penicillin/30,000 µg streptomycin solution. Cells were maintained under
normoxic conditions (5% CO2) at 37°C.
MTT analysis. HepG2 and U251 cells were seeded at 8000 cells/well in 96-well plates. DABA
was added at the indicated concentrations along with fresh media daily for 4 days. On the fifth
day, 0.6mg/ml MTT reagent was added to the cells and incubated at 37°C for 3 hours. The quantity
of viable cells was measured by recording the changes in absorbance at 570 nm using a plate
reading spectrophotometer.
Animal Care and Handling. Wildtype Zebrafish (Danio rerio), AB strain, were handled in
compliance with local animal care regulations and standard protocols for Canada and following
the University of Windsor animal care protocol #16-04. Original colony were formed through
breeding of zebrafish purchased from Pet Wise Pet Supplies store in Windsor, Ontario, Canada.
Adults were housed in an Aquaneering zebrafish housing system. Adult fish were kept at 26°C,
pH 7.6, DO 5.1 mg/L with a 14:10 light:dark cycle. Adult fish were bred according to standard
protocols (Westerfield, 1993).
Zebrafish Treatment and Analysis. Eggs were collected after fertilization and kept in E3 embryo
media (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, 0.33mM MgSO4, 0.0003% Methylene Blue)
at 32 °C in an incubator; pH 7 and under a 14:10 light: dark cycle (hours). DABA exposure. A
stock solution of 55 mM of DABA in DI water was diluted to the indicated measured
concentrations (10 µM, 50µM, 100µM, 300µM, 400µM, 500µM, 600µM, 700µM, 1mM, 2mM,
3.5 mM, and 4mM) in system water. At 18 hours post fertilization (hpf), eggs were placed in
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multiple 96-well plates, one egg per well. A total of 10 eggs per replicate (30 eggs per treatment
total) were utilized to determine hatching ability. Eggs were treated with 100µl of the indicated
concentrations of DABA daily, and water and DABA was changed every 24 hours. The number
of viable embryos and the number of unhatched eggs were counted and imaged using a Leica
Stereoscope in this unblinded study. At 3 days post fertilization (dpf), embryos were placed one
fish per well in 96-well plates and treated with 100 µl of the indicated diluted concentrations of
DABA daily. A total of 30 embryos per concentration were used; 10 embryos per replicate for
each endpoint readout. Viability, health, and heartbeat were quantified and imaged. Heartbeat was
measured by removing each embryo from its well in the 96-well plate and placed on a slide with
40 µl of embryo water. Heartbeat was monitored microscopically for 1 minute intervals and
recorded. Pigmentation level was determined using ImageJ software through the creation of a
histogram for each embryo at each concentration. The mean pixel level was determined as an
average of the pigmentation intensity for each fish (30 fish per treatment were analyzed). At both
1 month and 3 months of age, 10 fish per replicate were retrieved from a 3L stock tank and were
placed in a smaller 1L tank and treated with 500 ml of the indicated concentrations of DABA daily
and their viability was assessed. Daily water changes. Water changes from 96-well plates were
performed using a micropipettor, waste water was disposed of in a glass container labelled for
cytotoxic waste. Water changes for adult fish were performed by removing the fish from one
container and transferring them into a new container with 500 ml of fresh water dosed with the
indicated concentration of DABA.
Histological Methods. Following analysis of fish at 1 month, fish were humanely sacrificed, and
embedded in paraffin. Briefly, fixation of fish was done overnight in 4% paraformaldehyde in PBS
at 4°C. Fish were then washed in PBS and embedded (embryo) or stored in 20% EDTA (pH 8.0)
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for 10 days prior to embedding. Paraffin embedding was carried out according to standard
procedures, and 8 µm sections were cut. For histology, sections were dewaxed, dried and stained
with Haematoxylin and Eosin (H&E). H&E was carried out according to manufacturer’s protocol:
3-minute incubation followed by 10-minute washing in running tap water.
Spinning Task Assay. To assess 3-month-old adult zebrafish swimming endurance, we performed
the spinning task assay as previously published with minor modifications (Blazina, Vianna, &
Lara, 2013). We amended the protocol, lowering the rpm of rotation, to account for the smaller
size and decreased swimming ability of our 3-month-old fish compared to either the >8-month fish
Blazina and colleagues used, or the 5-month old fish examined by Powers and coworkers (Powers
et al., 2017). Fish were tested in a 1L opaque beaker containing 800 ml of DABA diluted in system
water to the required concentration. The water was heated to 26°C and placed on a hot plate stirrer
with indicated rpm (VWR, #12365-382). Zebrafish were acclimatized to the beaker for 10 minutes
prior to testing. Three tests were performed in which zebrafish were monitored and timed as they
swam against a current generated by a 9 x 50 mm bar spinning at 100 rpm. Swimming time was
recorded using a stopwatch and was defined as the amount of time before the fish were swept up
by the whirlpool current created by the stir bar.
Statistical analysis. All experiments were performed in triplicate and repeated three times. All
results are expressed as the mean ± standard error of the mean. Statistical analysis was done using
the GraphPad Prism 5.01 software (GraphPad Software). Differences were compared using Oneway or Two-way ANOVA followed by Tukey multiple comparison tests to compare differences
among multiple groups. Differences with p<0.05 were considered significant.

Results
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DABA does not affect human cancer cells at high concentrations. Most early stagetoxicological tests of potentially biomedically relevant materials involve easy to conduct, highthroughput cell viability assays (Patrick, 2017). Since DABA is known to influence liver and
neural functions, we tested whether DABA could alter the metabolic activity of human liver
(HepG2) and brain (U251) cancer cells. Cells were seeded in 96-well plates and treated over 4
days with DABA, followed by MTT analysis. Neither cell type showed any response to the
addition of DABA (Figure 2); DABA appears to neither accelerate cancer cell growth or cause any
cytotoxicity at these doses. To test potential effects at the organ or organism-level, we moved to
examine effects in vivo using a zebrafish model.

DABA has toxicological effects in zebrafish in vivo at high concentrations. We know from the
work of others that DABA has deleterious effects at very high concentrations (>1 mM). To
determine long-term health effects of DABA at lower concentrations on vertebrate viability and
toxicity, we employed the Danio rerio (zebrafish) in vivo model at various life stages with
exposure periods of between 2 to 7 days. After 42 hours of treatment, the hatching ability of the
embryos from their chorion had become affected at the higher concentrations (Figure 3A, 400-700
µM). Even after 3 days of treatment, approximately 90% of the embryos treated with 700 µM did
not hatch from the chorion (Figure 3A).
As the concentration of DABA was increased, developmental abnormalities were seen,
including curved spine, yolk sac edema and a separated portion of the yolk sac (Figure 3B&C). At
a lower exposure concentration of 300 µM DABA, 60% of fish showed signs of peri-cardial edema
and yolk sac edema, while both control fish and those treated with 200 µM or less of DABA
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showed no signs of edema (Figure 3B). At higher concentrations, the rate of abnormalities seen
increased to 100% at 700 µM; including those who were manually unhatched from the chorion.
This extremely sharp demarcation in the dose response curve is unusual. Embryos at the lower
concentrations, 10, 50, 100 and 200 μM and even most of those at 300 μM, developed normally
after hatching with no apparent ill effects from exposure to DABA.

DABA does not alter the pigmentation of zebrafish. Lack of pigmentation can be indicative of
abnormal development, and over-pigmentation can be associated with cancer (Lister, 2002). This
makes it a useful screening tool for gross toxicity. Following hatching, treated zebrafish were
analyzed for altered pigmentation through ImageJ analysis of pictures taken of 30 different fish
per treatment. These measurements and calculations determined that there is no meaningful
difference in pigmentation levels (<4% variance), or any observable trend, regardless of DABA
dose at the tested concentrations (Figure S1).

DABA affects viability of embryo and adult zebrafish. To determine viability after hatching, 6
groups of 3-dpf fish were treated with increasing concentrations of DABA for up to 7 days. Fish
were evaluated for viability as well as for being stressed. Stress was defined as either having
trouble breathing, swimming, or remaining upright. After one day of treatment, approximately
81% of the fish survived at 700 µM while no fish survived at 3.5 mM (Table 1). By the second
day, no fish were alive at 2 mM, but no further deaths were observed at 700 µM (Table 1). At the
end of treatment, 700 µM and 1 mM showed similar viabilities with only 25-28% death, 3-18%
stressed, and 56-68% healthy (Table 1). However, at the lower concentration of 300 µM, few illeffects were observed, and the single observed death is within experimental error.
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Next, to determine the toxicity on mature fish, populations aged from 1 month (juvenile)
to 3 months old (adulthood), were treated with 500 ml of water with DABA concentrations ranging
from 0 to 4 mM. The 1-month old fish treated with 700 µM of DABA remained viable over all 3
days of treatment. The fish exposed to 1 mM of DABA showed 100% viability at 24 hours;
however, no fish survived after 48 hours (Figure 4A). We examined both juvenile and adult fish
brains and livers following treatment to determine whether we observed any physical
abnormalities. No gross difference in liver or brain structure was seen between control and treated
fish using H&E staining in any of the examined samples (representative images provided as Figure
4B). Neurotoxicity and hepatotoxicity are often associated with abnormalities in these organs
during development.
The 3-month old fish responded very differently. Within 15 minutes of being treated with
4 mM DABA 0% were viable, after 45 minutes 0% viability was seen for 1 and 2 mM DABA, and
after 1.5 hours 0% of fish were viable at 700 µM; however, 80% of fish were viable at 500 µM
DABA (Table 2). After 24 hours, no fish remained viable in the presence of 500 µM, however
those exposed to DABA at either 100 and 300 µM remained 100% viable. We continued to monitor
these two groups of fish for an additional 72 hours. These 3-month old fish exposed to these lower
levels of DABA did not suffer any deaths over the four day experiment. This viability data
indicates that the ability of the zebrafish to tolerate DABA from embryo to adult changes and that
adults tolerate a much lower concentration of DABA than the embryos, but that there is a dose that
shows no increase in mortality. Again, there is a very sharp cut-off in viability above 300 μM.
These data demonstrate that the ability of the fish to tolerate DABA changes from embryo to adult
stage. Interestingly this occurs without direct gross effects to the cells of the liver or brain,
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suggesting that the mechanism of toxicity may not be due to hepatotoxicity or neurotoxicity as
reported with higher concentrations of DABA.

Zebrafish swimming ability affected with increasing DABA concentration. To determine if a
short exposure of DABA could have an effect on the swimming ability, endurance, and motility
of the zebrafish, we modified the established spinning task protocol (Blazina et al., 2013). To
quantify endurance, 10 zebrafish were selected from each treatment group and tested in 3 separate
trials. A current was generated from a 100 rpm stir bar in 800 ml of system water or increasing
concentrations of DABA diluted in system water. Once the zebrafish were swept up by the current
and lost their orientation, the stopwatch was stopped, and the time was recorded. The control group
and that subjected to the lowest DABA concentration (100 µM) had identical success swimming
against the current, and their latency was also longer than that of the fish subjected to higher DABA
concentrations (300 and 500 µM) (Figure 5). These data support that short-term exposure of higher
DABA concentrations impairs zebrafish motility.

Heartbeat affected after exposure to high levels of DABA. Following treatment, potential sublethal effects of DABA were investigated by measuring the average heartbeat of the zebrafish
embryos at control (0 µM), 100 µM, 300 µM, and 700 µM concentrations. The average heartbeat
in the studied populations of embryos did not significantly change between control and 100 or 300
µM, staying consistent at 120-130 beats per minute (bpm) (Figure 6). This heartrate is consistent
with typical zebrafish embryonic heart-beat rates.(De Luca et al., 2014) However, at 700 µM there
is a slight, but not significant, increase in bpm after 72 hpf compared to control treated fish. After
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96 hpf we see a significant increase in bpm, followed by a significant decrease at 126 hpf (Figure
6).

Discussion and Conclusion
Although not envisioned to be used as a drug itself, the biological impact and toxicity of DABA
is of significant interest as it will form part of our drug delivery capsule. Our preliminary
investigations indicate that the operational DABA concentration will be around 20 μM. Testing
effects on cellular metabolism in vitro using human liver and brain cancer cells did not reveal any
adverse effects at concentrations as high as 2 mM. This was highly encouraging, but required
further testing using in vivo models. The related compound, BMAA has been shown to be
incorporated into proteins in place of structurally similar L-serine (Dunlop, Cox, Banack, &
Rodgers, 2013; Glover, Mash, & Murch, 2014) resulting in cellular toxicity, but DABA has never
been detected in proteins, and does not appear to work through this mechanism (Glover et al.,
2014). Instead it is reasonable to consider that toxicity might be due to its structural similarity to
GABA. At high concentrations, DABA has been shown to interfere in a irreversible
noncompetitive manner with carrier-mediated transport of GABA in rat synaptosomes (Levi,
Rusca, & Raiteri, 1976) acting as a reuptake inhibitor, so it is not unreasonable to believe that
toxicity proceeds through a systems-level mechanism that would not be detectable using a
traditional cell viability assay.
Testing systemic effects requires the use of an animal model; the high throughput nature
of zebrafish: fast maturation, low cost, and small size, made them highly appealing. Using this in
vivo toxicity model, we have demonstrated that DABA affects the viability in both adult and
embryonic zebrafish. Cardiotoxicity becomes a concern at concentrations of 300 μM or greater but
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has no observable effect below this value. The ability of zebrafish to hatch from their chorion was
affected at 700 µM DABA. Although beyond the scope of this study, it is possible that DABA
interferes with the proteolytic enzymes required for the chorion softening for hatching to occur
(Kim et al., 2004). Following hatching, morphological changes were seen in embryos treated with
increasing concentrations of DABA above 300 µM. Developmental abnormalities were seen in the
embryos including curved spine, yolk sac edema and a separated portion of the yolk sac. Again,
no effect is observed below this concentration threshold. The cause for these abnormalities is
unknown; however, it is consistent with the observation of developmental abnormalities in other
animal systems, such as the development of crooked toes when DABA was fed to chicks at high
concentrations (Arscott and Harper, 1963). DABA clearly causes developmental abnormalities at
high doses for young and embryonic organisms, however, we observe no ill effects whatsoever
below a threshold dose (<300 µM). These concentrations (100-300 μM) are approximately an
order of magnitude higher than our expected therapeutic concentrations. The toxicity profile of the
DABA on developing and adult zebrafish is also essential to delineating the potential safety profile
of this material. Interestingly, histology showed no gross structural abnormalities in the brain or
liver of fish treated with DABA, which was shown to cause brain abnormalities and liver toxicity
in rats, albeit at much higher concentrations (Mushahwar & Koeppe, 1963; O'Neal et al., 1968).
Perhaps the lower dosages did not result in these abnormalities or they did not develop within this
time frame. Behavioral analysis showed zebrafish swimming ability and motility was affected even
after short-term exposure to DABA above the threshold indicating the possible interference with
the GABA reuptake that can alter cognitive ability. As far as we are aware, this is the first report
identifying a lowest observed effect concentration (LOEC) for DABA toxicity in any animal
system and we cannot find any reports using such low levels of the amino acid. We observe no
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differences from control at concentrations below 300 μM: our observed LOEC for DABA in
zebrafish is consequently 300 μM and this preliminary value is supported by the multiple
independent measurements conducted.
Since the zebrafish were able to tolerate the threshold concentration and concentrations
below, we were not surprised to see a steady heart-rate across the lower concentrations (0-300
µM). However, as the heart-rate of fish exposed to higher concentrations of DABA were elevated,
it is possible that at these low µM concentrations, toxicity occurs through some form of metabolic
stress. This observation is completely consistent with the suspected GABA receptor inhibition
(DiMicco, Gale, Hamilton, & Gillis, 1979). The goal of this study was to determine whether
DABA is toxic at 20 μM, our concentration of interest for our application. Effects are not observed
at this low level. Although beyond the scope of this study, we believe that this model could prove
useful for examining the mechanism of toxicity. Known GABA receptor inhibitors could be
screened to determine whether the same impacts on zebrafish viability, hatching ability, heart rate
and behaviour are observed as noted in this study. Further work from our group examining the
toxicity will be necessary as the biomedical application development advances, especially
regarding DABA’s interactions with the GABA receptors and the two isoforms of glutamic acid
decarboxylase (GAD65 and GAD67). However, the stage of the technology development remains
too preliminary to currently justify these studies.
This project highlights the importance of integrating appropriate multi-organ models, such
as the zebrafish, early in a toxicology screen. Regardless, as the effective concentrations expected
to be used for our anticipated biomedical applications will be on the order of 20 μM, all the data
collected in this study indicates that the compound deserves further development and investigation.
Additional toxicity data will need to be gathered on the final formulation. This is a very early stage
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toxicity screen for the material. It both demonstrates the insufficiency of using in vitro cell-based
assays alone for suspected systems-based toxicity and demonstrates that zebrafish are an
inexpensive and very useful tool for early-stage toxicological evaluation of potential biomedicallyemployed chemical materials before resources are spent developing technologies that are
unacceptably toxic.
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Table 1. Viability of embryonic fish is affected with increasing DABA concentrations.
Zebrafish embryos (3 dpf) were placed one embryo per well of a 96-well plate and treated with
indicated DABA concentrations (100 µl per well). Concentrations of DABA was maintained both
before and after hatching. Fish were monitored for viability, stress, and death after each 24-hour
period. A stressed fish was defined as any fish that was having trouble breathing, swimming, or
remaining upright.

Day 1

Day 2

Day 3

Day 7

Control
100 µM
300 µM
700 µM
1 mM
2 mM
3.5 mM
Control
100 µM
300 µM
700 µM
1 mM
2 mM
Control
100 µM
300 µM
700 µM
1 mM
Control
100 µM
300 µM
700 µM
1 mM

Alive
(%)
100
100
92.4
81.5
56.1
21.7
0
100
100
98.0
73.6
73.2
0
100
100
100
80.4
73.2
100
100
83.1
56.6
67.8

Stressed
(%)
0
0
7.6
8.1
26.8
0
0
0
0
2.0
14.9
9.8
0
0
0
0
6.9
4.9
0
0
13.0
18.2
4.9

Dead
(%)
0
0
0
10.3
17.1
78.3
100
0
0
0
11.5
17.1
100
0
0
0
12.7
22.0
0
0
3.9
25.3
27.3
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Table 2. Viability of 3-month old fish is affected with increased DABA. Adult zebrafish (3month old) were treated with increasing concentrations of 500 ml DABA and monitored from 096 hrs (every 15 minutes for the first 1.5 hours, then at 24, 48, and 96 hours). The presented data
represents selected timepoints and illustrates the dose-dependency of adult zebrafish viability.
Concentration

Time

% Viable

Control (0 µM)

96 hrs

100
100

100 µM

300 µM

500 µM

700 µM

1 mM

2 mM

4 mM

24 hrs

100

96 hrs

100

24 hrs

100

96 hrs

100

45 mins

100

1.5 hrs

80

24 hrs

0

45 mins

100

1.5 hrs

0

15 mins

100

45 mins

0

15 mins

100

45 mins

0

15 mins

0
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